Skip to content

Lupin wins US FDA nod for sodium zirconium cyclosilicate to treat hyperkalemia

Shares of Lupin Ltd ended at ₹2,275.00, down by ₹85.00, or 3.60%, on the BSE.​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *